AMIA urges CMS and ASTP/ONC to advance patient-centered innovation by ensuring comprehensive, computable access to health data through standardized API and integration of patient voices in standards development. Recommendations emphasize digital identity, usability for older adults, and reducing documentation burden. AMIA calls for scalable, interoperable tools, robust privacy protections, and […]
AMIA, along with a coalition of over 80 medical and research organizations, wrote to Congressional leaders on June 10, 2025, expressing urgent concerns about the National Institutes of Health. The letter highlights three critical issues: scientists cannot access legally appropriated research funds despite excellent grant scores; NIH is being restructured […]
AMIA submitted comments to the CMS RFI: Unleashing Prosperity Through Deregulation of the Medicare Program recommending the elimination or significant streamlining of prior authorization (PA) requirements as the primary Medicare deregulation priority. We stand that PA creates substantial administrative burden, with physicians spending 2+ days weekly on approvals, while 80% […]
In response to the National AI R&D Strategic Plan RFI, AMIA calls for embedding healthcare priorities within AI research and development efforts. They advocate for ethical R&D practices grounded in transparency, safety, fairness, and equity. AMIA emphasizes the need for high-quality data, bias mitigation, and interdisciplinary collaboration to guide responsible […]
AMIA responded to the latest USCDI Version 6 Draft. There are numerous recommendations including proposing ASTP/ONC create a roadmap to incorporate USCDI+ with future iterations of USCDI. AMIA also recommended incorporating Environmental Determinants of Health (EDOH) alongside Social Determinants of Health (SDOH) to provide a comprehensive view of factors influencing […]
AMIA joined more than 75 organizations representing a broad coalition of scientific, research, public health, and academic associations, urging greater transparency surrounding potential large-scale Reduction in Force (RIF) and reorganizations within federal agencies critical to the nation's scientific enterprise and public health infrastructure.